Thalidomide-O-amido-C4-NH2 hydrochloride

Modify Date: 2025-08-26 18:50:28

Thalidomide-O-amido-C4-NH2 hydrochloride Structure
Thalidomide-O-amido-C4-NH2 hydrochloride structure
Common Name Thalidomide-O-amido-C4-NH2 hydrochloride
CAS Number 2245697-86-1 Molecular Weight 438.86
Density N/A Boiling Point N/A
Molecular Formula C19H23ClN4O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Thalidomide-O-amido-C4-NH2 hydrochloride


Thalidomide-O-amido-C4-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs[1].

 Names

Name Thalidomide-O-amido-C4-NH2 hydrochloride

 Thalidomide-O-amido-C4-NH2 hydrochloride Biological Activity

Description Thalidomide-O-amido-C4-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs[1].
Related Catalog
Target

Cereblon

In Vitro Thalidomide-O-amido-C4-NH2 is an amine intermediate (Compound 41), which can be used as is a heterobifunctional PROTAC BET degrader. The bromodomain and extra-terminal (BET) family proteins, consisting of BRD2, BRD3, BRD4, and testis-specific BRDT members, are epigenetic “readers” and play a key role in the regulation of gene transcription. BET proteins are considered to be attractive therapeutic targets for cancer and other human diseases. Recently, heterobifunctional small-molecule BET degraders have been designed based upon the proteolysis targeting chimera (PROTAC) concept to induce BET protein degradation[1]. Thalidomide-O-amido-C4-NH2 is a degron-linker (refer to Compound DL6-TL). Degron-linker-targeting ligand, wherein the linker is covalently bound lo at least one degron and at least one targeting ligand, the degron is a compound capable of binding to an ubiquitin ligase such as an E3 ubiquitin ligase (e g, cereblon), and the targeting ligand is capable of binding to the targeted protein (s)[2].
References

[1]. Zhou B, et al. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins withPicomolar Cellular Potencies and Capable of Achieving Tumor Regression.J Med Chem. 2018 Jan 25;61(2):462-481.

[2]. James Bradner, et al. Methods to induce targeted protein degradation through bifunctional molecules. WO 2017024317 A2.

 Chemical & Physical Properties

Molecular Formula C19H23ClN4O6
Molecular Weight 438.86

 Safety Information

Hazard Codes Xi
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.